Narcolepsy can lead to excessive daytime sleepiness, as well as cataplexy, a sudden loss of muscle tone. Other symptoms can include sleep paralysis and hallucinations that occur both during sleep ...

There are two forms of narcolepsy. In type 1, cataplexy is another symptom that involves sudden muscle weakness or paralysis. This symptom can occur suddenly and is usually when a person experiences ...

Paul P. Doghramji, MD, discusses the underdiagnosis of narcolepsy especially among younger individuals and how clinicians can address this.

Alixorexton is an oral selective orexin 2 receptor agonist expected to reduce excessive daytime sleepiness across hypersomnolence disorders such as narcolepsy.

The latest announcement is out from Alkermes ( ($ALKS) ). On January 6, 2026, Alkermes announced that the U.S. Food and Drug Administration ...

Alkermes (NASDAQ:ALKS) used its presentation at the J.P. Morgan Healthcare Conference to outline its positioning entering ...

Alkermes (ALKS) shifts to fully integrated biopharma, leveraging Vibrance-2, Lybalvi growth, and Avadel buy to de-risk ...

Huntington's disease diagnosis is confirmed with a genetic test. A clinical history and medical evaluation are used to define symptom onset. Disease staging and surveillance for complications are ...

Alkermes (ALKS) announced that the FDA has granted Breakthrough Therapy Designation to alixorexton, a novel, investigational, ...

St. Luke’s University Health Network opens a $1.8M expanded Sleep Lab at its Miners Campus, boosting access to sleep disorder ...

Millions of Americans suffer from sleep disorders that can lead to serious health issues, including heart disease, diabetes ...